Vincera Pharma Inc
(VINC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,310 | -6,276 | -10,722 | -344 | -37 |
| Depreciation Amortization | -51 | -25 | 20 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,339 | -30 | 456 | 191 | 34 |
| Other Working Capital | 4,105 | 1,498 | -959 | 196 | 36 |
| Other Operating Activity | -8,695 | 1,396 | 8,926 | -187 | -33 |
| Operating Cash Flow | $-11,612 | $-3,437 | $-2,279 | $-144 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -228 | N/A | 0 | N/A | N/A |
| Purchase Sale Intangibles | -5,000 | -5,000 | N/A | N/A | N/A |
| Other Investing Activity | -5,000 | -5,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-5,228 | $-5,000 | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 64,371 | 201 | N/A |
| Debt Repayment | N/A | N/A | -300 | N/A | N/A |
| Common Stock Issued | 40,671 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | -21 | 0 |
| Financing Cash Flow | $40,671 | $N/A | $64,071 | $180 | $N/A |
| Beginning Cash Position | 61,792 | 61,792 | 0 | N/A | N/A |
| End Cash Position | 85,623 | 53,355 | 61,792 | 36 | N/A |
| Net Cash Flow | $23,831 | $-8,437 | $61,792 | $36 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,612 | -3,437 | -2,279 | -144 | N/A |
| Capital Expenditure | -228 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -11,840 | -3,437 | -2,279 | -144 | 0 |